Been watching Medlab closely for a while now & I think they're...

Been watching Medlab closely for a while now & I think they're at an inflection point.

Based on this quarterly it appears they could quite possibly escape the need for any further CR's...at least for the balance of CY22.

The ownership breakdown is very attractive, particularly with S.H owning around 17-18%.

Is revenue now mostly generated by Nanabis sales on compassionate grounds post the recent divestment?

Unprofitable Biotech has been beaten down tremendously and is bound to turnaround soon. I hope to find my way in before then.

Cheers & good luck.